Skip to main content
Premium Trial:

Request an Annual Quote

Pangea Releases Latest Version Of GeneWorld

Premium

OAKLAND, Calif.--Pangea Systems has released GeneWorld 3.5, an upgraded version of its sequence analysis and annotation software package. New features will further enable researchers to accelerate gene discovery and "take the next step towards elucidating a gene's function," the company claimed. Pangea said an advanced pipeline architecture lets users "create strategies that function on multiple sequences, as well as strategies with sequence annotation and masking components."

Using Pangea's Unified Life Science Environment application programming interface, the company said its customers can extend GeneWorld to operate with existing bioinformatics systems and solutions developed in-house or purchased from third-party vendors.

Filed under

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.